222 related articles for article (PubMed ID: 17676354)
1. Differential increase of CD34, KDR/CD34, CD133/CD34 and CD117/CD34 positive cells in peripheral blood of patients with acute myocardial infarction.
Grundmann F; Scheid C; Braun D; Zobel C; Reuter H; Schwinger RH; Müller-Ehmsen J
Clin Res Cardiol; 2007 Sep; 96(9):621-7. PubMed ID: 17676354
[TBL] [Abstract][Full Text] [Related]
2. Factors influencing spontaneous mobilization of CD34+ and CD133+ progenitor cells after myocardial infarction.
Turan RG; Brehm M; Koestering M; Tobias Z; Bartsch T; Steiner S; Picard F; Ebner P; Schannwell CM; Strauer BE
Eur J Clin Invest; 2007 Nov; 37(11):842-51. PubMed ID: 17973780
[TBL] [Abstract][Full Text] [Related]
3. Enhanced functional response of CD133+ circulating progenitor cells in patients early after acute myocardial infarction.
Vöö S; Eggermann J; Dunaeva M; Ramakers-van Oosterhoud C; Waltenberger J
Eur Heart J; 2008 Jan; 29(2):241-50. PubMed ID: 18156140
[TBL] [Abstract][Full Text] [Related]
4. Granulocyte colony-stimulating factor mobilizes functional endothelial progenitor cells in patients with coronary artery disease.
Powell TM; Paul JD; Hill JM; Thompson M; Benjamin M; Rodrigo M; McCoy JP; Read EJ; Khuu HM; Leitman SF; Finkel T; Cannon RO
Arterioscler Thromb Vasc Biol; 2005 Feb; 25(2):296-301. PubMed ID: 15569821
[TBL] [Abstract][Full Text] [Related]
5. Circulating CD34+, CD133+, and vascular endothelial growth factor receptor 2-positive endothelial progenitor cells in myelofibrosis with myeloid metaplasia.
Massa M; Rosti V; Ramajoli I; Campanelli R; Pecci A; Viarengo G; Meli V; Marchetti M; Hoffman R; Barosi G
J Clin Oncol; 2005 Aug; 23(24):5688-95. PubMed ID: 16110028
[TBL] [Abstract][Full Text] [Related]
6. Enhanced mobilization of CD34(+) progenitor cells expressing cell adhesion molecules in patients with STEMI.
Brehm M; Ebner P; Picard F; Urbien R; Turan G; Strauer BE
Clin Res Cardiol; 2009 Aug; 98(8):477-86. PubMed ID: 19479183
[TBL] [Abstract][Full Text] [Related]
7. The mobilization of CD34 positive mononuclear cells after myocardial infarction is abolished by revascularization of the culprit vessel.
Müller-Ehmsen J; Scheid C; Grundmann F; Hirsch I; Turan G; Tossios P; Mehlhorn U; Schwinger RH
Int J Cardiol; 2005 Aug; 103(1):7-11. PubMed ID: 16061116
[TBL] [Abstract][Full Text] [Related]
8. Distinct mobilization of circulating CD271+ mesenchymal progenitors from hematopoietic progenitors during aging and after myocardial infarction.
Iso Y; Yamaya S; Sato T; Poole CN; Isoyama K; Mimura M; Koba S; Kobayashi Y; Takeyama Y; Spees JL; Suzuki H
Stem Cells Transl Med; 2012 Jun; 1(6):462-8. PubMed ID: 23197850
[TBL] [Abstract][Full Text] [Related]
9. Circulating progenitor cells decrease immediately after marathon race in advanced-age marathon runners.
Adams V; Linke A; Breuckmann F; Leineweber K; Erbs S; Kränkel N; Bröcker-Preuss M; Woitek F; Erbel R; Heusch G; Hambrecht R; Schuler G; Möhlenkamp S
Eur J Cardiovasc Prev Rehabil; 2008 Oct; 15(5):602-7. PubMed ID: 18753954
[TBL] [Abstract][Full Text] [Related]
10. Endogenous G-CSF and CD34+ cell mobilization after acute myocardial infarction.
Leone AM; Rutella S; Bonanno G; Contemi AM; de Ritis DG; Giannico MB; Rebuzzi AG; Leone G; Crea F
Int J Cardiol; 2006 Aug; 111(2):202-8. PubMed ID: 16051386
[TBL] [Abstract][Full Text] [Related]
11. Mobilization of CD34/CXCR4+, CD34/CD117+, c-met+ stem cells, and mononuclear cells expressing early cardiac, muscle, and endothelial markers into peripheral blood in patients with acute myocardial infarction.
Wojakowski W; Tendera M; Michałowska A; Majka M; Kucia M; Maślankiewicz K; Wyderka R; Ochała A; Ratajczak MZ
Circulation; 2004 Nov; 110(20):3213-20. PubMed ID: 15533859
[TBL] [Abstract][Full Text] [Related]
12. Circulating CD34-positive cell number is related to effective myocardial reperfusion in acute myocardial infarction treated with primary coronary angioplasty.
Mariani M; De Servi S; Chianese R; Beria G; Gatti A; Poletti F; Del Rosso G; Fetiveau R; Poli A; Macchi M; Brando B
J Cardiovasc Med (Hagerstown); 2008 Jul; 9(7):677-82. PubMed ID: 18545066
[TBL] [Abstract][Full Text] [Related]
13. Progenitor Cells and Clinical Outcomes in Patients With Acute Coronary Syndromes.
Samman Tahhan A; Hammadah M; Raad M; Almuwaqqat Z; Alkhoder A; Sandesara PB; Mohamed-Kelli H; Hayek SS; Kim JH; O'Neal WT; Topel ML; Grant AJ; Sabbak N; Heinl RE; Gafeer MM; Obideen M; Kaseer B; Abdelhadi N; Ko YA; Liu C; Hesaroieh I; Mahar EA; Vaccarino V; Waller EK; Quyyumi AA
Circ Res; 2018 May; 122(11):1565-1575. PubMed ID: 29514830
[TBL] [Abstract][Full Text] [Related]
14. Osteocalcin positive CD133+/CD34-/KDR+ progenitor cells as an independent marker for unstable atherosclerosis.
Flammer AJ; Gössl M; Widmer RJ; Reriani M; Lennon R; Loeffler D; Shonyo S; Simari RD; Lerman LO; Khosla S; Lerman A
Eur Heart J; 2012 Dec; 33(23):2963-9. PubMed ID: 22855739
[TBL] [Abstract][Full Text] [Related]
15. Remote ischemic preconditioning immediately before percutaneous coronary intervention does not impact myocardial necrosis, inflammatory response, and circulating endothelial progenitor cell counts: a single center randomized sham controlled trial.
Prasad A; Gössl M; Hoyt J; Lennon RJ; Polk L; Simari R; Holmes DR; Rihal CS; Lerman A
Catheter Cardiovasc Interv; 2013 May; 81(6):930-6. PubMed ID: 22517646
[TBL] [Abstract][Full Text] [Related]
16. Bioactive lipids and cationic antimicrobial peptides as new potential regulators for trafficking of bone marrow-derived stem cells in patients with acute myocardial infarction.
Karapetyan AV; Klyachkin YM; Selim S; Sunkara M; Ziada KM; Cohen DA; Zuba-Surma EK; Ratajczak J; Smyth SS; Ratajczak MZ; Morris AJ; Abdel-Latif A
Stem Cells Dev; 2013 Jun; 22(11):1645-56. PubMed ID: 23282236
[TBL] [Abstract][Full Text] [Related]
17. Decreased number of circulating progenitor cells in obesity: beneficial effects of weight reduction.
Müller-Ehmsen J; Braun D; Schneider T; Pfister R; Worm N; Wielckens K; Scheid C; Frommolt P; Flesch M
Eur Heart J; 2008 Jun; 29(12):1560-8. PubMed ID: 18515295
[TBL] [Abstract][Full Text] [Related]
18. CD34-/CD133+/VEGFR-2+ endothelial progenitor cell subpopulation with potent vasoregenerative capacities.
Friedrich EB; Walenta K; Scharlau J; Nickenig G; Werner N
Circ Res; 2006 Feb; 98(3):e20-5. PubMed ID: 16439688
[TBL] [Abstract][Full Text] [Related]
19. Role of endothelial progenitor cells in restenosis and progression of coronary atherosclerosis after percutaneous coronary intervention: a prospective study.
Pelliccia F; Cianfrocca C; Rosano G; Mercuro G; Speciale G; Pasceri V
JACC Cardiovasc Interv; 2010 Jan; 3(1):78-86. PubMed ID: 20129574
[TBL] [Abstract][Full Text] [Related]
20. [Factors influencing mobilisation of endothelial progenitor cells and angiogenic cytokines after an extensive acute myocardial infarction].
Domínguez-Franco A; González FJ; Rodríguez-Losada N; Marchal JA; Cabrera-Bueno F; Carrillo E; Gómez-Doblas JJ; Perán M; Alonso-Briales JH; Jiménez-Navarro MF; Aránega A; De Teresa Galván E;
Med Clin (Barc); 2012 Apr; 138(10):415-21. PubMed ID: 22197368
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
